PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology ... San Antonio Breast Cancer Symposium (SABCS) taking place December 9-12.
News
- Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study ...
- Sterling Organization Announces Sale of Park North Shopping Center in San Antonio, Texas ...
... Biotechnology Banking & Financial Services Publishing & Media Chemicals ... San Antonio, Texas. Sterling Organization originally acquired the ...
- Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a ... - BioSpace
... San Antonio Breast Cancer Symposium. December 12, 2025 |. 5 min read ... Avenzo Therapeutics is a clinical-stage biotechnology company focused on ...
- Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine
("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology ... San Antonio Breast Cancer Symposium (SABCS). The trial was conducted in ...
- Anixa Biosciences' Breast Cancer Vaccine Safe, Well Tolerated In Phase 1 Study
(ANIX) presented encouraging final results from its Phase 1 clinical trial of its investigational breast cancer vaccine at the 2025 San Antonio Breast ...